Boule Diagnostics

Boule Diagnostics is a company specializing in the development, manufacturing, and marketing of diagnostic systems and consumables for hematology, primarily targeting the decentralized healthcare market. The firm serves small and midsize hospitals, clinics, and laboratories, as well as other diagnostic companies in both human and veterinary hematology. With a global distribution network that spans over 100 countries, Boule operates through subsidiaries in Sweden, the United States, and China. The company's origins trace back to the 1950s with the development of Europe’s first automatic blood cell counter, leading to its foundation in 1992 following the acquisition of Karo Bio Diagnostics AB. Boule's American subsidiary, Clinical Diagnostic Solutions Inc., also has historical ties to the creation of the first blood cell counter, further emphasizing the company's rich legacy in blood diagnostics.